Paola Omedè
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 71
- Hematopoietic Stem Cell Transplantation 15
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 14
- Oncology top 2%
- Cancer Treatment and Pharmacology 16
- Immunology top 5%
- Physiology top 5%
-
- Protein Degradation and Inhibitors 17
- Glycosylation and Glycoproteins Research 9
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- HIV/AIDS drug development and treatment 7
- Co-authors
- Mario BoccadoroAlessandro PileriAntonio PalumboCorrado TarellaGiovannino CicconeMassimo MassaiaSara BringhenSilvia Deaglio
- Cited by
- HematologyGeneticsOncology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (7 papers)Blood (32 papers)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Paola Omedè
105 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 93
- Hematology 1.7k
- Genetics 508
- Oncology 1.0k
- Immunology 553
- Physiology 103
Countries citing papers authored by Paola Omedè
This map shows the geographic impact of Paola Omedè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Omedè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Omedè more than expected).
Fields of papers citing papers by Paola Omedè
This network shows the impact of papers produced by Paola Omedè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Omedè. The network helps show where Paola Omedè may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paola Omedè, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2018 | 28 | |
| 3 | 2015 | 4 | |
| 4 | 2014 | 47 | |
| 5 | 2014 | 27 | |
| 6 | 2014 | 17 | |
| 7 | 2013 | 66 | |
| 8 | 2011 | 58 | |
| 9 | 2010 | 32 | |
| 10 | Report of the European Myeloma Network (EMN) workshop on multiparametric flow cytometry in multiple myeloma and related disorders | 2007 | 0 |
| 11 | 2007 | 320 | |
| 12 | 2006 | 20 | |
| 13 | 2006 | 136 | |
| 14 | SERUM FREE LIGHT CHAINS (SFLC) ASSAY: A SUGGESTIVE NEW CRITERIA FOR EVALUATING DISEASE RESPONSE, PROGRESSION AND RELAPSE IN PLASMA-CELL DISORDERS (PD) AND A PROGNOSTIC FACTOR IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) | 2006 | 1 |
| 15 | 2005 | 7 | |
| 16 | 2003 | 22 | |
| 17 | 1998 | 9 | |
| 18 | 1996 | 3 | |
| 19 | 1991 | 5 | |
| 20 | 1987 | 2 |
About Paola Omedè
Paola Omedè is a scholar working on Hematology, Genetics and Oncology, having authored 112 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (71 papers), Protein Degradation and Inhibitors (17 papers), Cancer Treatment and Pharmacology (16 papers), Hematopoietic Stem Cell Transplantation (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Glycosylation and Glycoproteins Research (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and HIV/AIDS drug development and treatment (7 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (508 citations) and Oncology (1.0k citations). Paola Omedè has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Mario Boccadoro, Alessandro Pileri, Antonio Palumbo, Corrado Tarella, Antonio Palumbo, Giovannino Ciccone, Massimo Massaia, Sara Bringhen, Silvia Deaglio and Paolo Corradini. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.